DNA methylation is now seen as a primary signal in the cell for mediating transcriptional repression through chromatin formation. The construction and evaluation of enzymes capable of in¯uencing this process in vivo is therefore of signi®cant interest. We have fused the C5-cytosine DNA methyltransferases, M.HhaI and M.HpaII, which both methylate 4 bp sequences containing a CpG dinucleotide, to a three zinc ®nger protein recognising a 9 bp DNA sequence. DNA methylation analyses demonstrate speci®c DNA methylation by both enzymes at target sites comprising adjacent methyltransferase and zinc ®nger subsites, targeted M.HpaII being the most speci®c. Binding analysis of the targeted M.HpaII enzyme reveals an 8-fold preference for binding to its target site, compared to binding to a zinc ®nger site alone, and an 18-fold preference over binding to a methyltransferase site alone, thereby demonstrating enhanced binding by the fusion protein, compared to its component proteins. Both DNA binding and methylation are speci®c for the target site up to separations of~40 bp between the zinc ®nger and methyltransferase subsites. Ex vivo plasmid methylation experiments are also described that demonstrate targeted methylation. These targeted enzymes, however, are shown to be not fully mono-functional, retaining a signi®cant non-targeted activity most evident at elevated protein concentrations.
INTRODUCTION
Members of the prokaryotic cytosine-5 DNA methyltransferase (C5-Mtase) family of enzymes share a high degree of amino acid sequence homology, most pronounced in 10 highly conserved regions (1, 2) . This homology to some extent re¯ects the shared catalytic function of all these enzymes, that of transferring a methyl group from the cofactor, S-adenosyl-L-methionine (AdoMet), to the 5 position of the target cytosine base in DNA. M.HhaI and M.HpaII are type II C5-Mtases from Haemophilus haemolyticus and Haemophilus parain¯uenzae, respectively, and recognise the speci®c DNA sequences 5¢-GCGC-3¢ and 5¢-CCGG-3¢, respectively, methylating the underlined cytosine in each instance. Crystal structures for one of these enzymes, M.HhaI, as well as for M.HaeIII, complexed with DNA and cofactor have been described (3, 4) . Whilst demonstrating subtle differences in DNA±protein contact signatures between the two proteins, both these studies revealed that in each case the target cytosine is¯ipped out of the DNA helix into the nucleotide-binding pocket of the enzyme, where the methyl transfer reaction can proceed. The functional characteristics of these enzymes, together with a wealth of information relating both amino acid sequence and structure to function, suggests to us that C5-Mtases may have potential as tools both in general research and in the treatment of disease, if their catalytic activity could be delivered to predetermined regions of the genome. The construction and evaluation of a three zinc ®nger fusion with a prokaryotic methylase was initially reported by Xu and Bestor (5) . While they were able to demonstrate a degree of targeted binding and methylation, they also suggested that the protein was not fully mono-functional, each component protein exhibiting a signi®cant independent activity. However, although members of the C5-Mtase family are highly homologous in terms of primary amino acid sequence, the functional characteristics of these proteins can vary signi®-cantly. For example, M.SssI, the methyltransferase used in this early work, contains both a processive methyltransferase activity (6) and a topoisomerase activity (7) , both of which would be expected to modulate gene targeting by a zinc ®nger protein, to varying extents. Therefore, in an effort to evaluate the properties of other C5-Mtases in a gene-targeted scenario, we have constructed fusions between a three zinc ®nger DNAbinding protein and the C5-Mtases M.HhaI and M.HpaII.
A primary application that we envisage for targeted C5-Mtases is as a tool for the study of the spread of methylation patterns within eukaryotes. While there is evidence that DNA methylation does spread from an initial focus (8±10), no clear trends or rules have been established. Recent observations, such as the existence of a novel family of mammalian C5-Mtases (11) and the role of histone deacetylases in mediating methylation-induced packaging of DNA (see below), suggest that a series of complex factors might exist that contribute to DNA methylation spreading in mammalian cells. Previous experimental procedures for studying methylation spread in vivo generally involved in vitro methylation and subsequent stable transfection of plasmid vectors (see for example 12) , with the integration site and¯anking sequences varying between each experiment. This makes interpretation of data extremely dif®cult, due to large variations in¯anking sequence effects. Furthermore, it has recently been demonstrated that the integration event itself can lead to marked alterations in the DNA methylation patterns of cellular genes and DNA segments (13) . Development of the enzymes described in this study will allow an alternative approach to the study of DNA methylation spread in eukaryotes that closely approaches the in vivo state. These enzymes, when expressed sequentially in a clonal cell line whose genome harbours a targetable DNA insert containing multiple C5-Mtase recognition sites, will enable a range of methylation densities to be generated at a de®ned locus, with a knowledge that both¯anking sequences and initial methylation status are identical in each instance.
A second potential application of targeted C5-Mtase enzymes stems from observations that mutation of the invariant catalytic cysteine of C5-Mtases to a glycine residue can generate an enzyme that binds with extremely high af®nity to its DNA recognition site (see for example 14, 15) . These proteins are cytotoxic when expressed in Escherichia coli and the ability to direct such toxic enzymes to speci®c and unique gene sequences within the mammalian cell may ultimately provide both greater insight into cellular repair processes and lead to a potential strategy for targeted cell death.
Lastly, the correlation between DNA methylation of eukaryotic gene promoters and transcriptional repression is widely accepted (for a review see 16, 17) and some of the mechanisms by which this relationship is implemented have been elucidated. These include reduced or abolished binding of transcription factors when their DNA binding site is methylated, as well as proteins that speci®cally bind to methylated DNA, thus occluding transcription factor binding directly. The observation that methylcytosine-binding proteins accelerate compaction of methylated DNA into a transcriptionally inactive chromatin form prompted studies that have revealed extensive interactions between methylcytosine-binding proteins and histone deacetylase proteins, mediated by a host of adaptor molecules (18±20). With these mechanisms in place within the cell, targeted promoter DNA methylation, accomplished using derivatives of the enzymes described in this study, may represent a novel gene therapy approach for the inheritable silencing of genes associated with disease. This would be of particular relevance in the case of viral genomes, which are known to be sensitive to promoter methylation.
We now report the construction and evaluation of ®rst generation targeted HhaI and HpaII C5-Mtases. These enzymes are assessed for their ability to speci®cally methylate targeted versus non-targeted DNA sequences. The most promising of these current enzymes, targeted HpaII, has been studied in more detail, both in terms of binding speci®city and af®nity for different DNA substrates as well as methyltransferase speci®city. The results of experiments designed to assess the cooperative interaction between the zinc ®nger and methyltransferase components of the fusion enzyme are also reported. The results of ex vivo studies are presented that point the way towards successful function of these enzymes under in vivo conditions in the mammalian cell.
MATERIALS AND METHODS

General reagents and chemicals
General reagents were supplied by Sigma unless otherwise stated. Restriction enzymes, Vent DNA polymerase, T4 DNA ligase and T4 polynucleotide kinase were purchased from New England Biolabs. Ultra pure deoxyribonucleotide solutions and poly(dI)´poly(dC) were purchased from Pharmacia Biotech. [g-32 P]ATP (>111 TBq/mmol) was purchased from ICN and [ 3 H-methyl]AdoMet (>1.85 TBq/mmol) from Amersham International. All oligodeoxynucleotides used in this study were synthesised by MWG BioTech (Germany), by the standard CE-phosphoramidite method.
Bacterial strains and plasmids
Escherichia coli ER1647 [F ± fhuA2 D(lacZ)r1 supE44 trp31 mcrA1272::Tn10(Tet r ) his-1 rpsL104(Str r ) xyl-7 mtl-2 metB1 D(mcrC-mrr)102::Tn10(Tet r ) recD1014] was used throughout this study and was obtained from New England Biolabs. Bacteria were grown in liquid culture in Luria±Bertani medium (1% w/v Tryptone, 1% w/v NaCl and 0.5% w/v yeast extract) and on LA medium (1% w/v Tryptone, 1% w/v NaCl, 0.5% w/v yeast extract and 1.5% w/v agar) supplemented, if appropriate, with antibiotics as described before (21) . The gene encoding the three zinc ®nger protein recognising the 9 bp sequence 5¢-GCAGAAGCC-3¢ (22) was a generous gift from Dr Yen Choo (LMB, University of Cambridge, UK). pUCHhaI and pUCHpaII are pUC18-based plasmids harbouring the entire M.HhaI and M.HpaII ORFs and were a kind gift from Dr Geoff Wilson (New England Biolabs). pGEX5X-3, pET22b and pLsyE (pACYC derivative) vectors were purchased from Pharmacia Biotech and Novagen.
Construction of targeted and non-targeted C5-Mtases
The gene encoding M.HhaI (Genbank accession no. J02677, bases 437±1420) was ampli®ed by PCR using pUCHhaI (10 ng) as template and primers complementary to the 5¢ end (5¢-GGCGCGGATCCTCGACTAGTGAATTCATGATTG-AAATAAAAGATAAACAGCTCACAGGATTACGCTT-T-3¢) and 3¢ end (5¢-GCGCGGTACCTTACTCGAG-ATATGGTTTGAAATTTAATGA-3¢) of the M.HhaI gene. The M.HhaI PCR product was restricted with BamHI and XhoI (underlined in the above primer sequences) and ligated into these same sites in pET22b to produce pHhaI. The PCR product was also ligated into the same sites in pGEX5X-3 in order to produce a non-targeted, GST±HhaI construct (pGHhaI).
Ampli®cation of the three zinc ®nger peptide described by Choo et al. (22) was performed using primers complementary to the 5¢ end (5¢-GCGCAAGCTTCGCATATGGCAGA-AGAGAAGCCTTTTCAGTGTCGAA-3¢) and 3¢ end (5¢-GCGCGGATCCCTTCTCGCCTGTGTGGGTCTTTAGGT-GTCTCTGAAGAGTAGC-3¢) of the three zinc ®nger gene. The start methionine codon of the ®rst zinc ®nger and end lysine codon of ®nger three are in bold in the respective primer sequence. The PCR product was restricted with NdeI and BamHI (underlined in the primer sequences above) and subcloned into these same sites in pHhaI, immediately 5¢ to the M.HhaI cDNA, to produce pzfHhaI. Double-stranded oligodeoxynucleotide coding for the¯exible (Gly 4 Ser) 3 peptide linker was subcloned between the BamHI and EcoRI restriction sites which separate the two cDNAs in pzfHhaI to produce pzfLHhaI. The resulting peptide sequence between the zinc ®nger and Mtase proteins was therefore TGEKGS(G 4 S) 3 SGEFM. Zinc ®nger and Mtase residues are underlined. The BamHI and EcoRI restriction sites are incorporated into the sequences coding for GS and EF dipeptides.
The zinc ®nger±linker±M.HhaI gene was excised from pzfLHhaI, as a NdeI±XhoI fragment, and ligated into a pGEX5X-3 vector containing a modi®ed multiple cloning site (P.J.Hurd, unpublished data), cut with the same enzymes to produce pGZfHhaI.
M.HpaII (Genbank accession no. L17342, bases 1594±2670) was ampli®ed by PCR using pUCHpaII (10 ng) as template and the following primers, complementary to the 5¢ end (5¢-GCGCGCGAATTCATGAAAGATGTGTTAG-ATGATAACTTGTTA-3¢) and 3¢ end (5¢-GCGCGCGTC-GACGTCATATAAATTTCCTAATTTTTCTAA-3¢). After restriction of the PCR product with EcoRI and SalI (sites underlined in the primer sequences above), the fragment was ligated into pGZfHhaI, pre-restricted with EcoRI and XhoI, resulting in direct replacement of the M.HhaI gene with that of M.HpaII (pGZfHpaII). Construction of a vector coding for M.HpaII as a fusion with GST was by direct ligation of the C5-Mtase as a BamHI±SalI fragment into the modi®ed pGEX5X-3 vector, to give pGHpaII. The integrity of constructs was con®rmed by sequencing.
Expression from all vectors allowed puri®cation of the recombinant protein via glutathione±agarose af®nity chromatography.
Protein expression and puri®cation
Recombinant plasmids were used to transform E.coli ER1647 cells and single colonies were used to induce high level expression of the targeted enzyme. Induction of protein expression was carried out as follows. A single colony was inoculated into 50 ml of LB medium containing 0.5% glucose, grown overnight at 37°C and cells were harvested by centrifugation. The cell pellet was resuspended in 1 ml of LB medium and then used to inoculate 500 ml of LB medium supplemented with 0.5% glucose and 100 mM ZnSO 4 . Growth was allowed to continue at 37°C until the OD 600 reached 0.8. Protein expression was induced by the addition of isopropylb,D-thiogalactopyranoside to a ®nal concentration of 1.0 mM and incubation was continued for a further 4 h at 30°C. Induced cells were harvested and lysed by sonication on ice; solubilisation of the recombinant enzymes was aided by the addition of Triton X-100 to 1% (v/v). Soluble recombinant enzymes were puri®ed to homogeneity (as judged by 10% SDS±PAGE and Coomassie blue staining; 21) by glutathione af®nity chromatography using glutathione±Sepharose (Sigma), essentially as described before (23) . All protein concentrations were determined by quantitative analysis of an SDS polyacrylamide gel containing sample protein and a protein standard of known concentration. Imaging was performed using a Las 1000 CCD camera (Fuji®lm) and Aida software (Raytest; Isotopenmessgera Ète, GmbH).
Gel retardation analysis
All oligodeoxynucleotides were annealed in 10 mM Tris±HCl, 10 mM MgCl 2 , 50 mM NaCl, 1 mM dithiothreitol (pH 7.9 at 25°C) in a PCR machine. Successful annealing was analysed by 3% agarose gel electrophoresis and ethidium bromide staining. Annealed oligodeoxynucleotide duplexes were labelled at the 5¢ end with [g-32 P]ATP using phage T4 polynucleotide kinase. Unincorporated label was removed by gel ®ltration using Bio-Spin-6 columns (Bio-Rad Ltd). Typically, 0.05 pmol targeted or non-targeted enzyme was incubated in C5-Mtase buffer (20 mM HEPES, pH 7.5, 5 mM dithiothreitol, 20 mM ZnSO 4 , 5 mM MgCl 2 , 50 mM KCl, 10% glycerol, 0.1% Nonidet P-40, 0.1 mg/ml BSA) with 0.03 pmol labelled double-stranded oligodeoxynucleotide and 300 ng poly(dI)´poly(dC), in a ®nal reaction volume of 30 ml. S-adenosyl-L-homocysteine (AdoHcy) was added to a ®nal concentration of 100 mM. Incubations were carried out for 35 min at room temperature. The reaction mixture was subsequently loaded onto a pre-run, 4% (w/v) non-denaturing polyacrylamide (acrylamide/bisacrylamide 19:1) gel in 1Q TBE buffer and electrophoresed for 1 h at 100 V at room temperature. Electrophoresis was carried out as described previously. All protein±DNA complexes were visualised after autoradiography with intensifying screens at ±70°C overnight. (The high levels of protein relative to probe concentrations that were used in gel retardation assays were dictated by the conditions that yielded signi®cant retardation of the probe, and therefore re¯ect the percentage activities of these protein preparations after the solubilisation and puri®cation steps described above.)
For dissociation constant determination, competitor oligonucleotide was added at time 0, over a ®nal concentration range 15.4±1078 nM (i.e. DNA always in excess). The reaction products were electrophoresed as described above. Dried down gels were imaged using an FLA-2000 Phosphorimager (Fuji). All experiments were performed at least in triplicate, unless stated otherwise, and used the same puri®ed protein preparation. The proportion of bound competitor DNA was determined by subtraction of the retarded probe signal in the presence of competitor from that of a control shift in the absence of competitor, which was assigned an arbitrary value of 1.0 (i.e. 100%), using the imaging software Aida. This ensured that each gel shift assay could be normalised relative to its own internal control. Data was plotted as amount of competitor bound (normalised against zero competitor level shift intensities) against total amount of competitor added in each binding reaction. Data was ®tted to the binding isotherm described by the equation [As an additional test of the data ®t, K d values derived from the non-linear regression approach described above were also compared with those calculated from data that were transformed and subjected to Scatchard analysis. In all cases, plots were clearly linear, suggesting single binding site kinetics, and K d values were found to be corroborative (data not shown). Attempts to ®t data to double binding site models failed in all cases.]
Oligodeoxynucleotide methylation assays
Unless otherwise stated, 1 pmol enzyme was incubated in the relevant C5-Mtase buffer (see previous section) with 3 pmol double-stranded oligodeoxynucleotide, 200 ng poly(dI)´poly(dC) and 1.65 mM [ 3 H-methyl]AdoMet in a ®nal reaction volume of 30 ml. Reactions were allowed to proceed for 30 min at 37°C before being stopped by the addition of SDS to 1% or AdoHcy (100 mM), followed by heat treatment for 5 min at 72°C in formamide gel loading buffer (21) . The reaction mixture was subsequently loaded onto a pre-run 6% (w/v) denaturing (7 M urea) polyacrylamide (acrylamide/ bisacrylamide 19:1) gel in 1Q TBE buffer and electrophoresed for 1 h at 100 V at room temperature. Following electrophoresis, gels were ®xed in 10% methanol, 10% acetic acid and either treated with the¯urographic reagent Amplify (Amersham International) or dried down directly. Duplexes that had been methylated were identi®ed by autoradiography with intensifying screens after 5 days at ±70°C. Titrational methylation assays were performed similarly to above, with protein and oligonucleotide concentrations as indicated in the relevant ®gures. Time course methylation assays contained 3 pmol duplex oligonucleotide and 20 fmol enzyme. For both these experiments, reactions were stopped by direct addition of formamide loading buffer and subsequent incubation at 85°C for 10 min. After electrophoresis, gels were treated and dried down as described previously and exposed overnight to a tritium imaging plate, which was subsequently scanned using an FLA 2000 Phosphorimager and quanti®ed using Aida software.
Ex vivo methylation assays
A double-stranded oligonucleotide with 3¢ terminal single A overhangs, and harbouring adjacent zinc ®nger (underlined) and HpaII (bold) recognition sites (core sequence 5¢-CTCCGGCTTCCATGGAGACGCAGAAGCCCT-3¢) was ligated into the pCR 2.1-Topo vector (Invitrogen) to generate the vector pZMol. A target site vector was made containing a larger insert but still containing only a single HpaII site. This was accomplished by PCR of pZMol using primers speci®c for the pCR 2.1-Topo vector at regions close to, but not including, the nearest¯anking HpaII sites to the site introduced by oligonucleotide insertion described above (5¢-AGCGGGCGCTAGGGCGCTGGCAAGTGT-3¢ and 5¢-GTAGTTGTGTGGAATTGTGAGCGGAT-3¢). The PCR product was then ligated into the pCR 2.1-Topo vector, to generate ZMTopo.
Ex vivo methylation analysis involved incubation of 0.5 mg ZMTopo vector with increasing concentrations of recombinant puri®ed targeted or non-targeted HpaII enzyme, in HpaII methylase buffer (see above) in the presence of 5 mM AdoMet, in a reaction volume of 10 ml. After either a 30 or 60 min incubation at 37°C, the reaction was stopped by heating the samples at 85°C for 10 min. The samples were then subjected to digestion by R.HpaII (0.2, 0.5 or 10 U) for 90 min at 37°C. Samples were analysed on a 1% agarose gel.
RESULTS
Plasmids coding for targeted methyltransferases are fully methylated in vivo
As a preliminary analysis of the targeted methylation properties of zinc ®nger±methyltransferase fusion enzymes, pGEX-based plasmids harbouring the genes for the GST±3Zf:HhaI or GST±3Zf:HpaII fusion proteins (henceforth referred to as Zf.M.HhaI and Zf.M.HpaII) and which contained multiple HhaI and HpaII restriction sites, were digested with HhaI or HpaII, respectively (Fig. 1A ). Both these plasmids were shown to be fully resistant to cleavage, demonstrating that the Mtases had retained biological activity (lanes 6 and 12). Our expectation had been that the presence of the zinc ®nger component would reduce the level of wild-type methylation observed by the Mtase component. In order to further examine the nature of the methylation that occurred during bacterial growth, a number of mutant targeted HpaII constructs were made. Firstly, removal of the methionine codon at position 1 in the HpaII gene of the targeted HpaII construct generated a mutant (Mut2) that similarly and predictably produced a fully methylated plasmid (see Fig. 1B , lane 5 compared to 6). However, additional mutations, in which frameshifts were introduced into the GST±3Zf:HpaII vector, either at the start of the zinc ®nger gene of Mut2 (Mut3, Zf.HpaII gene out of frame with GST gene) or between the zinc ®nger and HpaII genes in the wildtype construct (Mut1, HpaII gene out of frame with GST±Zf gene), also gave rise to fully protected plasmids (Fig. 1B , lane 7 compared to 8 and lane 3 compared to 4). SDS±PAGE analysis of induced protein expression for each of these mutants revealed protein products of the predicted size (see Fig. 1C ). Taken together, these results con®rm that while the correct transcription and translational signals are being used in the cell under inducing conditions, internal start codons are also being used in E.coli, which give rise to methyltransferases lacking a fully functional zinc ®nger targeting component and at levels suf®cient to fully methylate plasmid DNA under normal growth conditions. As such, further in vivo analysis of these enzymes in E.coli would have been uninformative under these conditions.
In the following series of experiments, gel retardation and methylation analyses were used to characterise the interaction between targeted C5-Mtases (i.e. with a zinc ®nger moiety) and control, non-targeted C5-Mtase (i.e. no zinc ®nger moiety) and DNA (oligonucleotides listed in Table 1 ). All experiments were carried out with glutathione S-transferase (GST) fused to the N-terminus of the recombinant enzymes via the zinc ®nger moiety (see Materials and Methods). The presence of GST has previously been demonstrated to Both the C5-Mtase and zinc ®nger recognition sites are underlined. ZfHhaI and ZfHpaII were also synthesised with 5-methyl-2¢-deoxycytosine at the target cytosine in the C5-Mtase recognition site. The target base is asterisked in the respective sequences. Where indicated in the text, 5-methyl-2¢-deoxycytosine was also present in the bottom strand at the corresponding symmetrically opposite target cytosine. [Only the top (5¢®3¢) strands are shown.] Base separation between subsites is measured from (and includes) the target cytosine in the HpaII site up to the ®rst base before the zinc ®nger site. have no effect on the activity of the C5-Mtase MspI, for example (24±26), or on the binding of zinc ®ngers to DNA (27, 28) .
Targeted C5-Mtases preferentially methylate DNA duplexes containing adjacent zinc ®nger and C5-Mtase recognition sites
The ability of Zf.M.HhaI to methylate DNA in a targeted manner was investigated by oligodeoxynucleotide methylation and competition±methylation assays. In order to discriminate between targeted and non-targeted methylation in the competition methyltransferase assays described, C5-Mtase site-containing oligodeoxynucleotides were synthesised as 29mers or 30mers (compared to 48mer target site oligodeoxynucleotides). This size difference enhances resolution of the two oligonucleotides during electrophoresis. The results of methylation assays designed to con®rm the ability of Zf.M.HhaI to methylate both strands of the target sequence are shown in Figure 2A . (The designation of`top' strand for all experiments described subsequently is de®ned by the sequence orientation of oligonucleotides listed in Table 1 .) The enzyme is clearly able to transfer tritiated methyl groups from [ 3 H-methyl]AdoMet to hemi-methylated cognate DNA duplexes ( Fig. 2A, lanes 2 and 3) . Duplexes that contained no C5-Mtase sites (lanes 5 and 6) or duplexes that were fully methylated (lane 4) were not subsequently methylated, con®rming that the methylation observed for non-methylated or hemi-methylated duplex target site DNA had occurred only at the HhaI site. A signi®cant level of methylation was observed by Zf.M.HhaI for duplexes that contained a HhaI site only (Fig. 2A, lane 7) .
The results of experiments designed to assess the ability of competitor oligonucleotides to modulate the methylation by Zf.M.HhaI of DNA substrates containing a HhaI site are presented in Figure 2B . Addition of target competitor duplex ZfHhaI (lanes 6±8) or duplexes that contain the zinc ®nger recognition site alone (lanes 2±4) cause a readily observable reduction in non-targeted methylation of duplexes containing only a M.HhaI site (lanes C), accompanied by a steady increase in degree of methylation of the competitor duplex (arrowed on the right hand side of Fig. 1B ). Effective and complete competition is observed even at equimolar levels when the competing duplex contained the zinc ®nger recognition and C5-Mtase sites, rather than duplexes containing a zinc ®nger recognition site alone.
In a repeat of the experiments described in Figure 2A for Zf.M.HhaI, the degree of non-targeted methylation of a 30mer oligonucleotide harbouring a single M.HpaII site by Zf.M.HpaII was only just detectable under conditions where the signal acquired by the target site-containing oligodeoxynucleotides was extremely intense (Fig. 2C , compare lanes 1±3 with lane 6). Indeed, in three additional repeats of this assay, non-targeted methylation of the HpaII* oligonucleotide by Zf.M.HpaII was not detectable at all (data not shown). Similarly to Zf.M.HhaI, Zf.M.HpaII is able to methylate either strand of the target duplex (Fig. 2C, lanes 2 and 3) .
Due to the extremely low levels of non-targeted DNA methylation produced by Zf.M.HpaII, the competition experiments described for Zf.M.HhaI in Figure 2B could not be performed with this enzyme. However, a series of alternative competition experiments were conducted using the Zf.M.HpaII enzyme, in order to examine the ability of either zinc ®nger site-containing or non-speci®c oligodeoxynucleotide sequences to compete with methylation of a target oligonucleotide (ZfHpaII). Results are shown in Figure 2D . Speci®c methylation of the target oligodeoxynucleotide is not signi®cantly affected by even a 10-fold molar excess of zinc ®nger site-containing oligodeoxynucleotide (Fig. 2D, lane 4) . Similar results were obtained for competition by non-speci®c duplex (lanes 6±8). These data further con®rm that the C5-Mtase component of the targeted enzymes contributes signi®cantly to the speci®city of the targeted enzyme as a whole.
Time course and titrational methylation assays were performed on Zf.M.HpaII in order to examine the relative catalytic activity at targeted and non-targeted Mtase sites. The results of titrational assays are shown in Figure 3A . The targeted enzyme is shown to catalyse methylation of the target oligonucleotide to an~11-fold higher level than a duplex harbouring an M.HpaII site only. The relative catalytic activity of Zf.M.HpaII for a duplex harbouring a zinc ®nger and adjacent C5-Mtase site is similar to that of nontargeted HpaII for an oligonucleotide harbouring a C5-Mtase site.
The results of time course methylation analyses, shown in Figure 3B , reveal a similar trend, with an 8-fold difference in activity for Zf.M.HpaII methylating target site-versus M.HpaII site-containing oligonucleotides. Only an~2-fold difference in catalytic activity was observed between targeted and non-targeted HpaII for ZfHpaII DNA.
Targeted HpaII C5-Mtase binds speci®cally and in cis to a recognition site comprising adjacent zinc ®nger and Mtase subsites
In order to obtain more quantitative binding data describing the interactions of such targeted enzymes with cognate and related sites, kinetic analyses of competition gel shift assays were performed on the Zf.M.HpaII and M.HpaII enzymes, as described in Materials and Methods. The competition approach ensures that within each set of comparative experiments identical levels of protein and probe are used, while the more readily quanti®able competitor DNA level is varied. (For all subsequent band shift assays reported the labelled duplex in each case was ZfHpaII; see Table 1 .) The gel shifts are shown in Figure 4A . For the self-competition experiment, a full gel is shown. (For all subsequent experiments throughout this work, only the region of the gel showing retarded probe is shown. Each gel ®gure shown represents one of a triplicate of experiments from which binding data were calculated.) While absolute K d values per se cannot realistically be determined via oligonucleotide competition approaches, highly reproducible relative K d values can be determined that are a proportional re¯ection of the binding af®nity of the enzyme for the various DNA substrates.
Binding analysis of the gel shifts shown in Figure 4A are shown in Figure 4B and reveal that Zf.M.HpaII binds to its target site with an apparent K d of 4.77 (T 0.93) Q 10 ±9 M, but binds to zinc ®nger or C5-Mtase sites alone with K d of 38.6 (T 3.9) and 86.8 (T 10.8) Q 10 ±9 M, respectively,~8-and 18-fold differences in binding af®nity, respectively. This result clearly demonstrates speci®c binding to a sequence comprising adjacent zinc ®nger and Mtase recognition sites. Under identical conditions, the three zinc ®nger protein (as a fusion to GST only) binds to its recognition site with an apparent K d of~14 Q 10 ±9 M (data not shown). M.HpaII binds to a M.HpaII site-containing oligonucleotide with a K d of 35.08 (T 7.9) Q 10 ±9 M, signi®cantly weaker than for Zf.M.HpaII binding its target site, but stronger than for Zf.M.HpaII binding just a HpaII site. Thus the targeted HpaII enzyme displays both an enhanced binding af®nity compared to its individual components and a reduced af®nity for individual subsites associated with each component of the fusion enzyme. Double competition binding experiments for Zf.M.HpaII, using a combination of the competitor duplexes HpaII and Zf, which contain single M.HpaII and zinc ®nger protein recognition sites, respectively, yielded an apparent K d of 93.65 (T 24.6) Q 10 ±9 M. This is a much larger value than found for binding target site and zinc ®nger site-containing oligonucleotides alone, despite the opportunity for interaction of each component of the fusion protein with its own recognition subsite, and suggests that both components of the targeted enzyme preferentially bind to linear DNA, with subsites arranged in cis. Competition experiments using an oligonucleotide in which the HpaII site replaced the ®rst 3 bp of the zinc ®nger subsite (zHpaII, bottom gel in Fig. 3A) gave an apparent K d of 169.4 (T 29.7) Q 10 ±9 M, again much larger than that found for binding to just a HpaII site-containing oligonucleotide. All these results taken together con®rm that the binding af®nity obtained for the interaction of the enzyme with the target site sequence is a result of both the C5-Mtase and zinc ®nger subunits of the targeted enzyme, acting in concert and in cis on the same DNA substrate.
Targeted HpaII binding is modulated by the methylation status of the target site
In this experiment, competitor oligonucleotides were synthesised in which either the top, bottom or both top and bottom strand target cytosine positions contained methylcytosine. Representative gel mobility titrations showing the effect of methylation status of the target site on binding of Zf.M.HpaII are shown in Figure 5A . Kinetic analysis of these data is shown in Figure 5B . The enzyme binds to the ZM3 oligonucleotide (bottom cytosine methylated) with an apparent K d of 4.28 (T 1.2) Q 10 ±9 M and to the ZM5 oligonucleotide (top strand Targeted HpaII C5-Mtase binds and methylates speci®cally at recognition sites with variable subsite spacing
The ability of the targeted HpaII C5-Mtase enzyme to bind speci®cally to oligodeoxynucleotides with an increasing base pair separation between the zinc ®nger and M.HpaII subsites was examined by gel retardation competition and oligonucleotide methyltransferase assays. Figure 6A shows the gel shift assays resulting from competition with duplexes harbouring zinc ®nger and M.HpaII subsites separated over the range 2±44 bp (oligonucleotides Sep2±Sep44, see Table 1 ). Figure 6B shows a plot of the binding af®nity of the enzyme for each subsite spacing. Also presented on the graph are the results of methylation assays for each oligonucleotide (for details see ®gure legend). The values have been normalised against the apparent K d values, so that they can be presented in the same ®gure. It is immediately apparent that binding and methylation curves correlate extremely well, being nearly mirror images of each other, i.e. as the apparent K d reduces (tighter binding) the methylation signal increases. A general area of tight binding and high methylation rate can be seen to occur from~10 bp up to~40 bp. Two local optima, coincident for both binding and methylation, centred at~13 bp and at 34 bp separation, may also be present. An extremely sharp transition point can be seen to occur between the 16 and 17 bp subsite separations, where both binding and methylation become weaker. This is a signi®cantly larger change than is seen for the 5 to 6 bp subsite spacing transition and probably re¯ects a`stress site', at which¯exibility of the fusion protein linker and the related orientational preference of the methylase component directly con¯ict with the spatial presentation of the target cytosines at the Mtase subsite.
Targeted HpaII speci®cally methylates plasmid DNA harbouring a target sequence ex vivo, against a background of non-targeted HpaII sites
The vector ZMTopo was constructed, harbouring a single targetable site (see Materials and Methods) but containing an additional 23 M.HpaII recognition sites. In the absence of any methylation, the target plasmid should yield a characteristic restriction pattern after digestion by R.HpaII. Speci®c methylation at the target site would result in an alteration of this restriction pattern, giving rise to a unique 1060 bp fragment. A schematic describing this rationale is shown in Figure 7A .
A titrational ex vivo methylation assay was performed, incubating target site plasmid ZMTopo with increasing amounts of recombinant Zf.M.HpaII, in order to simulate the in vivo scenario of methylating more complex substrates. The DNA was subsequently digested with R.HpaII and the digestion products analysed by agarose gel electrophoresis. The results are shown in Figure 7B . A band corresponding to the expected size of 1060 bp can be clearly seen, increasing in intensity in those lanes that had been incubated with Zf.M.HpaII (lanes 1±6), but not in lanes that had been incubated just with M.HpaII (lanes 7±12). The identi®cation of this band as being the target site-containing fragment was con®rmed by further digestion of the DNA with restriction enzymes whose sites only occurred within the target fragment (see Fig. 7A ). As can be seen in Figure 7C , upon restriction with EcoNI and BamHI, the 1060 bp fragment disappears.
The appearance of a unique band from the target site vector in this assay only when incubated with targeted enzyme and corresponding in size to that expected from the result of targeted methylation, and the con®rmation of predicted restriction enzyme sites within this fragment, con®rms our conclusion that targeted methylation is occurring under these conditions.
DISCUSSION
We have presented data describing the evaluation of fusion proteins comprising a three zinc ®nger protein covalently linked to either HpaII or HhaI Mtase via a¯exible peptide linker. The principle behind this approach was to bias the action of the Mtase component to speci®c recognition sites than were proximal to the 9 bp DNA sequence recognised by the zinc ®nger protein. The expectation of this initial approach would be that the intrinsic speci®city of each component of the fusion protein should remain unaltered, although one would expect changes in general binding af®nities for each component for its subsite, as part of a fusion protein. We have evaluated whether this was indeed the case in detail for the targeted HpaII enzyme, as well as examining orientational and subsite spacing preferences.
The initial discovery that plasmids encoding targeted methyltransferases were fully methylated suggested initially that fusion of a Mtase to the zinc ®nger protein did not modulate either Mtase activity or speci®city in E.coli. However, the observation of similar methylation by constructs speci®cally mutated so as not to express a functional targeted methyltransferase suggested that internal transcription and/or translation occurred from vectors coding for the targeted enzymes in E.coli. Given the repetitive nature of the DNA linker sequence joining the zinc ®nger and methyltransferase genes, the possibility of both translational and transcriptional stalling present themselves, allowing alternative`re-start' points for both events to re-occur along the template. Due to the nature of methyltransferases, only a small number of nontargeted molecules would need to be produced to fully protect the coding plasmid under typical overnight growth conditions. This property suggests methyltransferases as excellent reporters for constitutive and low level expression/translation studies. However, any evaluation of targeted methylation ef®cacy in bacteria using this current expression system was not possible, due to the considerations mentioned above. Comparative in vitro analysis of the catalytic activity of puri®ed Zf.M.HhaI and Zf.M.HpaII enzymes revealed that Zf.M.HhaI in fact catalyses a signi®cant level of methylation of duplexes harbouring a M.HhaI site alone (i.e. it is able to function as a discrete methyltransferase at some level, irrespective of its zinc ®nger component). Binding studies, however, revealed no interaction between targeted HhaI and this duplex (data not shown). Such non-targeted DNA methylation has also been described for the only other report of a targeted C5-Mtase, a fusion between a three zinc ®nger protein and the 5¢-CpG-3¢-speci®c prokaryotic SssI C5-Mtase (5). Consequently, this enzyme has limited use in in vivo applications. Non-speci®c methylation associated with the targeted M.SssI enzyme may be related to the observed processive action of this enzyme, proceeding along CpGcontaining substrate molecules and methylating one strand of DNA at a time. Such activity would exacerbate the level of non-targeted methylation expected. The HhaI and HpaII C5-Mtases, however, do not display the same processive characteristics as described for M.SssI (6) .
The results of methylation competition experiments described for targeted HhaI and HpaII broadly correlate with data from gel shift assays and provide con®rmation that both the DNA binding and DNA methylation events are targeted phenomena. The degrees of targeted and non-targeted methylation observed between these two enzymes might re¯ect differences in their 3-dimensional structures, which would modulate the interaction between the C5-Mtase and zinc ®nger moieties. It may be signi®cant that the N-terminal regions of each C5-Mtase differ in length before the start of homology block I (1,2). M.HhaI has 13 amino acids and M.HpaII has 34 amino acids in this region, which are fused directly to the linker sequence between the zinc ®nger and C5-Mtase components. Contributions made by each region to the overall nature and¯exibility of the existing linker region would be expected to modulate the characteristics of each enzyme and represent a potential avenue of exploration for additional studies aimed at further enhancing the speci®city of these enzymes. An earlier targeted HhaI prototype enzyme, containing a (Gly) 6 linker, was in fact non-functional (data not shown), and con®rms the importance of the linker sequence between the components of a fusion enzyme, as demonstrated in other studies (5,28±31).
Titrational and time course methylation assays on the targeted HpaII enzyme interacting with target and C5-Mtase site substrate oligonucleotides con®rmed methylation speci®-city and that the enzymatic properties of the C5-Mtase component of the targeted enzyme had not been impaired as a consequence of its fusion protein status. Interestingly, methylation of the shorter (30mer) duplexes by targeted M.HpaII was signi®cantly lower than for the longer DNA substrates (48mers) used in time course and titration assays, and may re¯ect a requirement for an initial non-speci®c interaction between Zf.M.HpaII and DNA before methylation proceeds at the speci®c site.
Binding studies on the active targeted HpaII enzyme are necessarily complicated by the fact that the Mtase component of the fusion enzyme has an intrinsic catalytic activity. During the course of a normal binding assay, for example, one would expect large protein conformational changes to occur as well as forced dissociation of the protein from the DNA subsequent to target site methylation. An additional aspect would be the generation of fully methylated and hemi-methylated DNA products that would re-enter the general pool of DNA to be rebound. A further complication lies in the proposed basē ipping mechanism associated with C5-Mtases, which may have an associated DNA`tracking' component and which might also be expected to distort the DNA. To counter the problems associated with catalysis interfering with accurate measurement of binding af®nities, we have performed all binding assays in the presence of the commonly used cofactor analogue AdoHcy, which lacks a methyl donor group. Thus catalytic acceleration of dissociation during the binding assay has been addressed to some degree.
Kinetic analysis of Zf.M.HpaII binding to a series of different oligonucleotides representing target sequence permutations revealed that the highest af®nity interaction was found for Zf.M.HpaII binding to its full target site, which was 8-fold tighter than to a zinc ®nger site oligonucleotide and 18-fold tighter than to a Mtase site oligonucleotide. These results con®rm that the targeted enzyme displays a binding af®nity greater than either of its component parts, although the greater contribution is most likely from the zinc ®nger moiety and suggests a degree of cooperativity between each component in the binding event. Evidence of cooperativity in binding also exists, from the results of double competition experiments using separate Zf-and Mtase site-containing competitor oligonucleotides. The resultant apparent K d values are signi®cantly larger than for the protein binding to target site or zinc ®nger site oligonucleotides alone and are in fact more comparable to that of binding to a methylase sitecontaining oligonucleotide. This is an unusual result, since one would expect the zinc ®nger oligonucleotide component of the double titration assay to exert a similar competitive effect as in previous experiments, when it was sole competitor. It can only be inferred that the fusion enzyme cannot interact with subsites located on separate DNA molecules with the same ef®ciency as each protein would in its wild-type form, or that such interactions are now short lived due to steric problems. For example, crystal structure analysis of the HhaI Mtase and its complex with DNA shows that signi®cant conformational changes occur upon DNA binding (3), and it is conceivable that such movement in the methyltransferase component of the targeted enzyme would lead to a reduction in zinc ®nger±DNA interactions in a trans binding scenario. Similarly, competition by the mutated zinc ®nger site oligonucleotide zHpaII, in which the HpaII site directly encroaches into the zinc ®nger site to the extent that only 6 of the original 9 bp of the zinc ®nger site are present, is signi®cantly less effective than by a simple HpaII site-containing oligonucleotide, and again argues for a cooperative (albeit negative in this instance) effect.
Similar`bi-modal' binding systems, such as covalently linked zinc ®nger multi-arrays or zinc ®nger±transcription factor fusion enzymes, have also been shown to demonstrate cooperativity in binding between component proteins when similarly analysed (32, 33) . Such cooperativity as seen in these and our own study, where the binding af®nity for the hybrid target site is signi®cantly greater than the af®nity of each protein component for its respective site, is thought to be largely due to an enhanced local concentration of each protein component on the DNA. This is due to`tethering' of each component near the DNA, as a consequence of binding of the other component to its recognition subsite. Cooperative interactions might also arise due to direct interaction between component proteins of the fusion enzyme, resulting in an enhancement of their DNA binding af®nity. Linker-associated interactions may also contribute to the binding event.
Binding studies using pre-methylated competitor duplexes showed that the C5-Mtase component of Zf.M.HpaII preferentially interacts with the top strand of the target duplex. This is most likely attributable to the¯exibility of the linker peptide joining the zinc ®nger and C5-Mtase components. The lower binding af®nity observed for the fully methylated duplex re¯ects the fact that a fully methylated Mtase site is no longer a substrate for methylation and thus not an optimal binding site. Signi®cantly, DNA methylation analysis of both the Zf.M.HhaI and Zf.M.HpaII enzymes revealed that these enzymes are capable of transferring methyl groups to both strands of the target sequence at the respective C5-Mtase subsites. In contrast to gel shift competition assays, however, under the conditions of these methylation experiments no obvious strand preference can be inferred.
The ability of Zf.M.HpaII to speci®cally bind duplexes with variable spacing between the zinc ®nger and C5-Mtase subsites was shown to correlate with the methylation activity of the enzyme for each oligonucleotide. In both instances, maximum activity/af®nity occurred over the range 10±40 bp separation between subsites. Within this region, evidence for the existence of two local optima is observed at 13 and 32 bp. These¯uctuations fall at an interval corresponding to whole helical turns of DNA and are not inconsistent with the target cytosines being optimally positioned for interaction with the methylase component of the fusion enzyme at these particular subsite spacings. The ability of the C5-Mtase component to speci®cally recognise and bind its subsite up to 44 bp away from the anchored zinc ®nger subunit suggests great potential for this enzyme construct in delivering methylation over a signi®cant length of DNA. The binding af®nity at this separation (26 nM) is still stronger than that of the protein binding to just a zinc ®nger site (38 nM). Interestingly, binding of the enzyme to DNA with a subsite separation of only 2 bp was still signi®cantly tighter than to oligonucleotides with in®nite' spacing (i.e. the Zf and HpaII oligonucleotides). This suggests, rather surprisingly, that even at such a close subsite separation, where in fact the HpaII and zinc ®nger sites overlap but are maintained (see Table 1 ), both components of the fusion enzyme are still contributing to the binding event in a cooperative manner. This conclusion is also in accord with results obtained for binding of the protein to the zHpaII oligonucleotide previously discussed. Given that when the linker can be considered either relaxed (at 2 bp subsite separation) or extended (at 44 bp separation) cooperative binding is still observed, it seems unlikely that the linker contributes signi®cantly to the cooperative binding event.
Preliminary titrational methylation assays had suggested that the DNA:protein ratio may represent a critical factor for the successful function of these targeted enzymes. This conclusion was con®rmed when methylation analysis of a target site plasmid revealed successful targeted methylation at the target site and where the majority of vector DNA was unmethylated. Such targeted methylation occurred at speci®c ratios of protein:DNA concentration, which we have calculated to be in the range 1:10±1:50. This observation is also signi®cant, given that in vivo studies on the zinc ®nger protein activation of target promoters has shown that at high cellular protein concentrations, non-speci®c binding and transcriptional activation from non-target site-containing promoters was observed (34) .
Here we have constructed targeted C5-Mtases that can methylate DNA in a targeted manner. In the absence of a target site, these enzymes are not absolutely mono-functional, although Zf.M.HpaII is close to being so. When the enzymes are presented with both target site-and non-target sitecontaining DNA, methylation occurs at the target site in preference to any other. The targeted HpaII enzyme displays the most speci®c binding and methylation attributes and has been shown to be able to deliver targeted methylation over at least a 35 bp region. Methylation analyses using complex substrates, such as target site vectors, more closely approach in vivo conditions and have shown that targeted methylation is achievable at speci®c ratios of protein to DNA.
However, a key problem still exists with these enzymes, which is that the level of normal, i.e. non-targeted, methylation is quite high. In the absence of target sites, the af®nity of the targeted enzyme for Mtase sites alone is high enough for signi®cant methylation to occur. Second generation targeted enzymes are therefore currently being evaluated, in which the C5-Mtase moieties harbour mutations that result in reduced DNA binding af®nity at the Mtase recognition site and reduced catalytic activity (27) . Such lower activity would be compensated for by the tethering effect of the zinc ®nger component, which should occur only at the target site. These approaches should signi®cantly reduce, if not eliminate, nontargeted methylation. Additionally, the zinc ®nger protein used in this study has only moderate binding af®nity for its recognition site and targeting could certainly be further enhanced by use of tighter binding zinc ®nger proteins or larger zinc ®nger arrays.
While there is still room for signi®cant advances to be made in this area, these current and future enzymes represent valuable tools for the study of DNA methylation spread and control in in vivo studies, as well as potential effectors for targeted promoter gene silencing induced through a DNA methylation-mediated cellular response.
